2seventy bio, Inc.
TSVT
$4.98
$0.010.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.93M | 13.53M | 8.97M | 12.44M | 10.68M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.93M | 13.53M | 8.97M | 12.44M | 10.68M |
| Cost of Revenue | 17.50M | 14.09M | 19.47M | 48.43M | 54.36M |
| Gross Profit | -14.57M | -554.00K | -10.50M | -36.00M | -43.68M |
| SG&A Expenses | 8.52M | 12.88M | 9.86M | 12.66M | 16.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.02M | 26.97M | 29.32M | 61.09M | 70.57M |
| Operating Income | -23.09M | -13.44M | -20.36M | -48.65M | -59.88M |
| Income Before Tax | -19.52M | -9.93M | 24.88M | -52.67M | -56.82M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.52M | -9.93M | 24.88M | -52.67M | -56.82M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.52M | -9.93M | 24.88M | -52.67M | -56.82M |
| EBIT | -23.09M | -13.44M | -20.36M | -48.65M | -59.88M |
| EBITDA | -21.44M | -11.78M | -18.68M | -46.55M | -56.85M |
| EPS Basic | -0.37 | -0.19 | 0.48 | -1.01 | -1.11 |
| Normalized Basic EPS | -0.23 | -0.11 | -0.20 | -0.54 | -0.69 |
| EPS Diluted | -0.37 | -0.19 | 0.45 | -1.01 | -1.11 |
| Normalized Diluted EPS | -0.23 | -0.11 | -0.19 | -0.54 | -0.69 |
| Average Basic Shares Outstanding | 52.33M | 52.26M | 52.19M | 52.07M | 51.38M |
| Average Diluted Shares Outstanding | 52.33M | 52.26M | 55.01M | 52.07M | 51.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |